Details for New Drug Application (NDA): 018366
✉ Email this page to a colleague
The generic ingredient in CHYMEX is bentiromide. There are three drug master file entries for this compound. Additional details are available on the bentiromide profile page.
Summary for 018366
Tradename: | CHYMEX |
Applicant: | Savage Labs |
Ingredient: | bentiromide |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;ORAL | Strength | 500MG/7.5ML | ||||
Approval Date: | Dec 29, 1983 | TE: | RLD: | No |
Expired US Patents for NDA 018366
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Savage Labs | CHYMEX | bentiromide | SOLUTION;ORAL | 018366-001 | Dec 29, 1983 | ⤷ Sign Up | ⤷ Sign Up |
Savage Labs | CHYMEX | bentiromide | SOLUTION;ORAL | 018366-001 | Dec 29, 1983 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription